PATENT CLAIM ANALYSIS

Application Number: 16283669
Application Type: Utility
Filing Date: 2019-02
Publication Date: 2019-06
Patent Classification: ["424", "093210"]

Abstract:
The present disclosure is generally related to methods for combining chemotherapy and immunotherapy for the treatment of a cancer. The methods also relate to generating a drug-resistant cytotoxic immune cell line and uses thereof in conjunction with cytotoxic drugs

Claim (Index 8):
The kit of  claim 7 , wherein the chemotherapy agent is a cytotoxic chemotherapeutic agent.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 99.0
- Lexical Diversity: 1.21212
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14283478', '13772944', '13642221', '15117811', '15302450']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7145145430114361
- 35 USC 102 Novelty (BERT): 0.5975379988375067
- Combined Prediction Score: 0.7028168885940431
- Mean Citation Score: 335.060918
- Max Citation Score: 567.2819999999998
- Similarity Product: 406.89869761490814

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test